BHST (BioHarvest Sciences) Long-Term Capital Lease Obligation : $9.14 Mil (As of Dec. 2024)

View and export this data going back to 2019. Start your Free Trial

What is BioHarvest Sciences Long-Term Capital Lease Obligation?

BioHarvest Sciences's Long-Term Capital Lease Obligation for the quarter that ended in Dec. 2024 was $9.14 Mil.

BioHarvest Sciences's quarterly Long-Term Capital Lease Obligation increased from Jun. 2024 ($9.22 Mil) to Sep. 2024 ($9.50 Mil) but then declined from Sep. 2024 ($9.50 Mil) to Dec. 2024 ($9.14 Mil).

BioHarvest Sciences's annual Long-Term Capital Lease Obligation declined from Dec. 2022 ($1.67 Mil) to Dec. 2023 ($1.43 Mil) but then increased from Dec. 2023 ($1.43 Mil) to Dec. 2024 ($9.14 Mil).

BioHarvest Sciences Long-Term Capital Lease Obligation Historical Data

The historical data trend for BioHarvest Sciences's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioHarvest Sciences Long-Term Capital Lease Obligation Chart

BioHarvest Sciences Annual Data

Trend

Apr15

Apr16

Apr17

Apr18

Apr19

Dec20

Dec21

Dec22

Dec23

Dec24

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

2.40

2.27

1.67

1.43

9.14

BioHarvest Sciences Quarterly Data
	Jan20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial															1.43	0.73	9.22	9.50	9.14

BioHarvest Sciences (NAS:BHST) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

BioHarvest Sciences Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of BioHarvest Sciences's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

BioHarvest Sciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » BioHarvest Sciences Inc (NAS:BHST) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

8MV0:Germany

Address

1140-625 Howe Street, Vancouver, BC, CAN, V6C 2T6

Website

https://www.bioharvest.com

BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. This company is the industrial large-scale plant cell growth technology capable of directly and constantly producing active plant ingredients without the necessity to grow the plant itself. The company is focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinical therapeutic solutions, within two business verticals - nutraceutical health and wellness products such as dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients (APIs) that focus on specific medical indications.